Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

2.0K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychological interventions for asthma in children and adolescents.

The Cochrane database of systematic reviews·2024
Same author

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews·2023
Same author

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.

The Cochrane database of systematic reviews·2022
Same author

Macrolides versus placebo for chronic asthma.

The Cochrane database of systematic reviews·2021
Same author

The safety and efficacy of SLIT compared to placebo or standard care for children with asthma.

Paediatric respiratory reviews·2021
Same author

Sublingual immunotherapy for asthma.

The Cochrane database of systematic reviews·2020

Related Experiment Video

Updated: Apr 4, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.8K

Sublingual immunotherapy for asthma.

Rebecca Normansell1, Kayleigh M Kew, Amy-Louise Bridgman

  • 1Population Health Research Institute, St George's, University of London, London, UK, SW17 0RE.

The Cochrane Database of Systematic Reviews
|August 29, 2015
PubMed
Summary
This summary is machine-generated.

Sublingual immunotherapy (SLIT) for asthma shows a trend towards benefit but lacks sufficient data for definitive conclusions. While serious adverse events are rare, SLIT increases the risk of mild, transient side effects.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K

Related Experiment Videos

Last Updated: Apr 4, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.8K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K

Area of Science:

  • Respiratory Medicine
  • Allergy and Immunology
  • Clinical Trials Research

Background:

  • Asthma affects 300 million globally, with half having an allergic component.
  • Sublingual immunotherapy (SLIT) aims to induce immune tolerance to allergens.
  • The safety and efficacy of SLIT for asthma require further investigation.

Purpose of the Study:

  • To evaluate the efficacy and safety of sublingual immunotherapy (SLIT).
  • To compare SLIT with placebo or standard care in adult and pediatric asthma patients.

Main Methods:

  • Systematic review and meta-analysis of parallel randomized controlled trials (RCTs).
  • Inclusion of studies on adults and children with asthma, irrespective of severity.
  • Data extraction and risk of bias assessment by two independent reviewers.

Main Results:

  • Fifty-two studies with 5077 participants were included; most were placebo-controlled.
  • Limited data on key outcomes like exacerbations and quality of life.
  • SLIT showed a trend towards symptom improvement but increased overall adverse events (mild, transient).

Conclusions:

  • Insufficient data prevents definitive conclusions on SLIT's clinical utility for asthma.
  • Further research with validated scales and patient-centered outcomes is necessary.
  • SLIT's safety in moderate-to-severe asthma remains unevaluated; increased risk of mild adverse events noted.